英文名稱 |
中文名稱 |
CAS號 |
操作 |
Cimetidine EP Impurity A |
西咪替丁二縮物 |
52378-40-2 |
詳細(xì)
|
Cimetidine EP Impurity B |
N-氰基-N'-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫基]乙基]亞胺代氨基甲酸甲酯 |
138035-55-9 |
詳細(xì)
|
Cimetidine EP Impurity F |
西咪替丁EP雜質(zhì)F |
55272-86-1 |
詳細(xì)
|
Cimetidine EP Impurity H |
N-氰基-3-(氰基氨基)-N'-甲基-7,8-二硫雜-2,4,11-三氮雜十二碳-2-烯-12-甲脒 |
74886-59-2 |
詳細(xì)
|
Cimetidine EP Impurity I |
4-羥甲基-5-甲基咪唑 |
29636-87-1 |
詳細(xì)
|
Cimetidine EP Impurity J DiHCl |
鹽酸西咪替丁EP雜質(zhì)J |
38603-72-4 |
詳細(xì)
|
Atomoxetine EP Impurity B HCl |
阿托莫西汀S-異構(gòu)體 |
82857-39-4 |
詳細(xì)
|
Theophylline Impurity 1 |
對甲苯磺酸羥乙酯 |
42772-85-0 |
詳細(xì)
|
Levocarnitine EP Impurity A |
巴豆 |
927-89-9 |
詳細(xì)
|
Levocarnitine EP Impurity B |
DL-樟腦酸 |
5394-83-2 |
詳細(xì)
|
Levocarnitine EP Impurity C |
|
64532-04-3 |
詳細(xì)
|
Levocarnitine EP Impurity D |
(3-氨基甲酰烯丙基)三甲基銨 |
857162-57-3 |
詳細(xì)
|
Doxazosin Impurity 1 |
1,4-苯并二噁烷-2-甲酸甲酯 |
3663-79-4 |
詳細(xì)
|
Doxazosin Impurity 3 |
甲磺酸多沙唑嗪雜質(zhì)17 |
931232-18-7 |
詳細(xì)
|
Atomoxetine EP Impurity A |
阿托西汀EP 雜質(zhì) A |
56161-70-7 |
詳細(xì)
|
Atomoxetine EP Impurity A HCl |
托莫西汀EP雜質(zhì)A |
873310-33-9 |
詳細(xì)
|
Atomoxetine Impurity 1 |
托莫西汀相關(guān)物質(zhì)B |
873310-28-2 |
詳細(xì)
|
Tigecycline EP Impurity C |
米諾環(huán)素 |
10118-90-8 |
詳細(xì)
|
Tigecycline EP Impurity D |
替加環(huán)素雜質(zhì)1 |
1138343-10-8 |
詳細(xì)
|
Tigecycline Impurity 3 |
替加環(huán)素USP雜質(zhì)C |
1633815-62-9 |
詳細(xì)
|
Famotidine EP Impurity H DiHCl |
(S)-((2-胍基-4-噻唑基)甲基)異硫脲二鹽酸鹽 |
88046-01-9 |
詳細(xì)
|
Sibutramine Impurity 2 |
1-[1-(4-氯苯基)環(huán)丁基]-3-甲基丁胺鹽酸鹽 |
84484-78-6 |
詳細(xì)
|
Atomoxetine Impurity 2 |
對甲基阿托西汀鹽酸 |
873310-31-7 |
詳細(xì)
|
Fudosteine Impurity 1 |
福多司坦雜質(zhì) |
50727-79-2 |
詳細(xì)
|
Omeprazole EP Impurity F and G Mixture |
Omeprazole EP Impurity F and G mixture |
|
詳細(xì)
|
Doxycycline hyclate EP Impurity A |
6-差向多西環(huán)素 |
3219-99-6 |
詳細(xì)
|
Doxycycline hyclate EP Impurity B |
甲烯土霉素 |
914-00-1 |
詳細(xì)
|
Ciprofloxacin EP Impurity A |
環(huán)丙羧酸 |
86393-33-1 |
詳細(xì)
|
Ciprofloxacin EP Impurity B HCl |
環(huán)丙沙星 EP 雜質(zhì) B HCL |
2727369-47-1 |
詳細(xì)
|
Ciprofloxacin EP Impurity C |
環(huán)丙沙星雜質(zhì)C |
103222-12-4 |
詳細(xì)
|
Ciprofloxacin Impurity 7 |
Ciprofloxacin N-Oxide |
860033-22-3 |
詳細(xì)
|
Apixaban Impurity 11 |
Ethanedioic acid, monoethyl ester, 2-(4-methoxyphenyl)hydrazide |
2614-10-0 |
詳細(xì)
|
Apixaban Impurity 12 |
(Z)-2-氯-2-(2-(4-甲氧基苯基)亞肼基)乙酸甲酯 |
70736-27-5 |
詳細(xì)
|
Apixaban Impurity 14 |
(Z)-2-氯-2-(2-(2-甲氧基苯基)亞肼基)乙酸乙酯 |
85014-68-2 |
詳細(xì)
|
Apixaban Impurity 15 |
2-氯-2-[2-(4-乙氧基苯基)肼-1-亞基]乙酸乙酯 |
37522-29-5 |
詳細(xì)
|
Apixaban Impurity 19 |
1-(4-硝基苯)-1H-吡啶-2-酮 |
53427-97-7 |
詳細(xì)
|
Apixaban Impurity 20 |
Acetic acid, 2-chloro-2-[2-(3-methoxyphenyl)hydrazinylidene]-, ethyl ester, (2Z)- |
2228998-99-8 |
詳細(xì)
|
Apixaban Impurity 22 |
Apixaban impurity 14/6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid |
1704504-93-7 |
詳細(xì)
|
Tigecycline EP Impurity A |
替加環(huán)素USP雜質(zhì)E |
1422262-97-2 |
詳細(xì)
|
Tigecycline EP Impurity B |
替加環(huán)素代謝物M6 |
149934-19-0 |
詳細(xì)
|
Atomoxetine EP Impurity C HCl |
托莫西汀EP雜質(zhì)C鹽酸鹽 |
1643684-06-3 |
詳細(xì)
|
Lornoxicam Impurity 18 |
氯諾昔康雜質(zhì)16 |
106820-59-1 |
詳細(xì)
|
Lornoxicam Impurity 19 |
氯諾昔康雜質(zhì)13 |
59804-27-2 |
詳細(xì)
|
Lornoxicam Impurity 23 |
氯諾昔康雜質(zhì)34 |
1030422-51-5 |
詳細(xì)
|
Lornoxicam Impurity 24 |
氯諾昔康雜質(zhì)23 |
167023-62-3 |
詳細(xì)
|
Lornoxicam Impurity 26 |
5-HYDROXY LORNOXICAM |
123252-96-0 |
詳細(xì)
|
Meloxicam Impurity 2 |
2-((5-甲基噻唑-2-基)氨基)-2-氧代乙酸 |
82514-69-0 |
詳細(xì)
|
Meloxicam Impurity 4 |
2-磺基苯甲酸 |
632-25-7 |
詳細(xì)
|
Tolnaftate Impurity 2 |
6,6 -氧代雙- 2 -萘磺酸二鈉鹽 |
61551-82-4 |
詳細(xì)
|
Metformin Impurity 1 |
N-(亞氨基甲基)-N,N-二甲基硫脲 |
118632-64-7 |
詳細(xì)
|
Metformin Impurity 2 HCl |
(N,N-二甲基氨基甲酰氨基)脲鹽酸鹽 |
570410-57-0 |
詳細(xì)
|
Hydroxychloroquine Sulfate EP Impurity A |
硫酸羥氯喹EP雜質(zhì)A |
1449223-88-4 |
詳細(xì)
|
Hydroxychloroquine Sulfate EP Impurity B |
Hydroxychloroquine O-Sulfate |
103152-84-7 |
詳細(xì)
|
Hydroxychloroquine EP Impurity C |
克尼托喹 |
4298-15-1 |
詳細(xì)
|
Hydroxychloroquine Sulfate EP Impurity D |
羥基氯喹EP雜質(zhì)D-d5二鹽酸 |
1476-52-4 |
詳細(xì)
|
Hydroxychloroquine Sulfate EP Impurity E |
4-[(7-氯-4-喹啉)氨基]-1-戊醇 |
10500-64-8 |
詳細(xì)
|
Hydroxychloroquine Sulfate EP Impurity F |
羥基氯喹雜質(zhì) |
6281-58-9 |
詳細(xì)
|
Hydroxychloroquine Sulfate EP Impurity G |
4,7-二氯喹啉 |
86-98-6 |
詳細(xì)
|
Hydroxychloroquine O-Acetate |
羥氯喹雜質(zhì)7 |
47493-14-1 |
詳細(xì)
|
Dutasteride EP Impurity E |
Dutasteride 17 Alpha Epimer |
2102935-76-0 |
詳細(xì)
|
Dutasteride EP Impurity F |
度他雄胺雜質(zhì)D |
1365545-42-1 |
詳細(xì)
|
Dutasteride EP Impurity G |
度他雄胺EP雜質(zhì)G |
1430804-85-5 |
詳細(xì)
|
Dutasteride EP Impurity I |
度他雄胺EP雜質(zhì)I |
1648593-70-7 |
詳細(xì)
|
Tacrolimus Impurity 2 |
他克莫司甲基丙烯醛 |
109466-74-2 |
詳細(xì)
|
Tacrolimus Impurity 5 |
他克莫司雜質(zhì)2 |
131944-48-4 |
詳細(xì)
|
Thioctic Acid Impurity 2 |
硫辛酸雜質(zhì) 42 |
91140-37-3 |
詳細(xì)
|
Glutathione EP Impurity A |
半胱氨酰甘氨酸 |
19246-18-5 |
詳細(xì)
|
Glutathione EP Impurity B |
L-半胱氨酸 |
52-90-4 |
詳細(xì)
|
Glutathione EP Impurity C |
L-谷胱甘肽 (氧化型) |
27025-41-8 |
詳細(xì)
|
Ritonavir EP Impurity B |
利托那韋EP雜質(zhì)B |
765875-58-9 |
詳細(xì)
|
Ritonavir EP Impurity E |
雷托那韋雜質(zhì)E |
176655-56-4 |
詳細(xì)
|
Ritonavir EP Impurity F |
利托那韋EP雜質(zhì)F |
1010809-61-6 |
詳細(xì)
|
Ritonavir EP Impurity G |
利托那韋EP雜質(zhì)G |
2034136-66-6 |
詳細(xì)
|
Ritonavir EP Impurity H |
利托那韋雜質(zhì)H |
1010809-43-4 |
詳細(xì)
|
Ritonavir EP Impurity I |
利托那韋EP雜質(zhì)I |
165315-26-4 |
詳細(xì)
|
Ritonavir EP Impurity J |
(2S,3S,5S)-5-(叔丁氧羰基氨基)-2-(N-5-噻唑基甲氧羰基)氨基-1,6-二苯基-3-羥基己烷 |
162849-95-8 |
詳細(xì)
|
Ritonavir EP Impurity L |
利托那韋雜質(zhì)L |
256328-82-2 |
詳細(xì)
|
Ritonavir EP Impurity N |
利托那韋EP雜質(zhì)N |
202816-62-4 |
詳細(xì)
|
Ritonavir EP Impurity O |
利托那韋EP雜質(zhì)O |
1414933-81-5 |
詳細(xì)
|
Ritonavir EP Impurity Q |
利托那韋雜質(zhì)17 |
1414933-82-6 |
詳細(xì)
|
Ritonavir EP Impurity T |
Ritonavir EP Impurity T |
869368-48-9 |
詳細(xì)
|
Furosemide Impurity 8 |
呋塞米雜質(zhì)5 |
62971-57-7 |
詳細(xì)
|
Mometasone Furoate EP Impurity F |
糠酸莫米松雜質(zhì)F |
1305334-30-8 |
詳細(xì)
|
Cefoperazone EP Impurity D |
7-氨基-3-(1,2,3-三唑-4-硫代)甲基-頭孢環(huán)-4-羧酸 |
37539-03-0 |
詳細(xì)
|
Amikacin EP Impurity I |
(S)-(-)-4-氨基-2-羥基丁酸 |
40371-51-5 |
詳細(xì)
|
Lornoxicam Impurity 8 |
3-(Aminosulfonyl)-5-chlorothiophene-2-carboxylic acid |
1017791-22-8 |
詳細(xì)
|
Amikacin EP Impurity D |
單硫酸卡那霉素 |
59-01-8 |
詳細(xì)
|
Furosemide Impurity 5 |
呋塞米雜質(zhì)13 |
1870323-25-3 |
詳細(xì)
|
Furosemide Impurity 6 |
呋塞米雜質(zhì)06 |
33069-75-9 |
詳細(xì)
|
Lornoxicam Impurity 17 |
5-氯-3-(N-乙酸甲酯-N-甲基氨基磺酰基)-噻吩-2-甲酸甲酯 |
70374-38-8 |
詳細(xì)
|
Sulbactam EP Impurity D |
溴巴坦 |
26631-90-3 |
詳細(xì)
|
Amikacin Impurity 1 |
阿米卡星雜質(zhì) |
1793053-92-5 |
詳細(xì)
|
Mometasone Furoate EP Impurity B |
糠酸莫米松雜質(zhì)B |
223776-49-6 |
詳細(xì)
|
Mometasone Furoate EP Impurity C |
(16Α)-21-氯-17-[(2-呋喃基羰基)氧基]-16-甲基孕甾-1,4-二烯-3,11,20-三酮 |
1305334-31-9 |
詳細(xì)
|
Amikacin Impurity 2 |
4-O-(6-氨基-6-脫氧-ALPHA-D-吡喃葡萄糖基)-N1-[(2S)-4-氨基-2-羥基-1-氧代丁基]-2-脫氧-D-鏈霉胺 |
1793053-90-3 |
詳細(xì)
|
Amikacin EP Impurity H |
AMikacin B |
48237-20-3 |
詳細(xì)
|
Amikacin Impurity 3 |
阿米卡星雜質(zhì)12 |
40371-54-8 |
詳細(xì)
|
Furosemide Impurity 7 |
3,4-二氯-5-(氯磺?;?苯甲酸 |
151104-67-5 |
詳細(xì)
|
Lornoxicam Impurity 10 |
氯諾昔康雜質(zhì) |
72975-44-1 |
詳細(xì)
|
Cefoperazone EP Impurity A |
頭孢哌酮雜質(zhì) A |
73240-08-1 |
詳細(xì)
|